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SS : swimming speed 
SWS : slow wave sleep 
TBS : tris buffer saline 
TBS-T20 : tris buffer saline-Tween 20 
TBS-TX : tris buffer saline- Triton X-100 
TEM : transmission electron microscopy 
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PERUBAHAN STRUKTUR, EKSPRESI PROTEIN DREAM, BDNF DAN CREB 
DI DALAM HIPOKAMPUS; DAN PEMBELAJARAN RUANGAN DAN 
MEMORI TERHADAP TIKUS YANG MENGALAMI KEKURANGAN TIDUR 
PERGERAKAN MATA CEPAT (REM) SELEPAS RAWATAN NIKOTIN AKUT  
ABSTRAK 
 Kekurangan tidur fasa ‗pergerakan mata cepat‘ (REMsd) telah terbukti 
menganggu tahap pembelajaran ruangan dan keupayaan memori, manakala rawatan 
nikotin akut berupaya mengelakkan kesan tersebut. Kajian ini dijalankan untuk 
menyiasat mekanisme REMsd dan penggunaan nikotin dalam menghalang gangguan 
pembelajaran ruangan dan memori dengan menyiasat ekspresi ‗downstream regulatory 
element antagonist modulator’ (DREAM), ‘cyclic AMP response element binding 
protein’ (CREB), dan ‘brain-derived neurotrophic factor’ (BDNF); dan perubahan 
ultraselular sel-sel hipokampus tikus REMsd. Tikus Sprague Dawley jantan yang 
berusia 10 minggu dan mempunyai berat sekitar 200-250 g telah dibahagikan kepada 
enam kumpulan. Kumpulan pertama (Kawalan (C), n=24) dan kedua (Kawalan dan 
nikotin (CN), n=24) terdiri daripada tikus kawalan yang bebas bergerak; kumpulan 3 
(REMsd (R), n=24) dan 4 (REMsd dan nikotin (RN), n=24) terdiri daripada tikus 
dengan REMsd yang diaruh menggunakan teknik pasu tertangkup selama 72 jam; 
kumpulan kelima (Platform lebar (W), n=24) dan keenam (Platform lebar dan nikotin 
(WN), n=24) terdiri daripada tikus yang terdedah kepada persekitaran eksperimen yang 
sama seperti tikus REMsd, tetapi pasu tertangkup untuk kumpulan ini adalah lebih lebar, 
dan membolehkan tikus tidur. Kumpulan C, R, dan W disuntik secara subkutaneus 
dengan salin manakala kumpulan CN, RN dan WN disuntik dengan 1 mg/kg nikotin 
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secara subkutaneus setiap 12-jam sekali selama 72 jam. Kaedah ‗Morris Water Maze’ 
(n=36), digunakan untuk menentukan pembelajaran ruangan dan memori, dimana 5 hari 
pertama adalah ujian ‗escape latency‘, manakala pada hari terakhir ujian ‗probe’. 
Pengambilan makanan dan berat badan setiap kumpulan tikus diukur semasa tempoh 
penyesuaian, tempoh induksi 72 jam dan semasa tempoh ujian MWM. Bagi setiap 
kumpulan, hippocampi telah dikeluarkan untuk imunohistokimia (IHC) (n=36), 
pemblotan Western (WB) (n=36), dan analisis mikroskop transmisi elektron (TEM) 
(n=36) secara berasingan. REMsd dalam kumpulan R dan RN disahkan melalui 
hiperfagia dan kehilangan berat badan. Dalam tikus kumpulan R, gangguan 
pembelajaran ruangan dan memori dapat di kesan; analisis TEM menunjukkan 
kerosakan dalam sitoplasma, nukleus, mitokondria, retikulum endoplasma kasar (RER) 
dan alat golgi (GA); IHC memperlihatkan bahawa tikus-tikus ini mempunyai jumlah 
neuron positif DREAM yang lebih banyak, tetapi bilangan neuron-neuron pCREB dan 
BDNF yang lebih sedikit pada kawasan hippocampal iaitu ‗cornu ammonis’ (CA) - 
CA1, CA2 CA3, dan ‗dentate gyrus’ (DG); dan keputusan ini konsisten dengan analisis 
WB. Tikus-tikus dari kumpulan RN yang dirawat nikotin menunjukkan kesan REMsd 
yang berkurangan. Kesimpulannya, kajian ini menunjukkan bahawa rawatan nikotin 
akut terhadap REMsd boleh mengurangkan gangguan pembelajaran dan memori ruang 
dengan (1) mengurangkan kerosakan ultrastruktur hippocampus, (2) mengurangkan 
ekspresi dan aras protein DREAM, dan (3) meningkatkan ekspresi dan aras protein 
pCREB dan BDNF, dalam hippocampi tikus REMsd. 
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STRUCTURAL CHANGES, EXPRESSION OF DREAM, BDNF AND CREB 
PROTEINS IN THE HIPPOCAMPUS; AND SPATIAL LEARNING AND 
MEMORY OF RAPID EYE MOVEMENT (REM) SLEEP-DEPRIVED RATS 
UPON ACUTE NICOTINE TREATMENT  
ABSTRACT 
 Rapid eye movement sleep deprivation (REMsd) has been shown to disturb 
spatial learning and memory performance, while acute nicotine treatment prevented 
these effects. This study was conducted to investigate the mechanisms of REMsd and 
the use of nicotine in preventing impairments in spatial learning and memory by 
investigating the expression of ‗downstream regulatory element antagonist modulator’ 
(DREAM), ‘cyclic AMP response element binding protein’ (CREB), and ‘brain-derived 
neurotrophic factor’ (BDNF) proteins; and ultracellular changes in the rat‘s 
hippocampal cells. Ten-week-old male Sprague Dawley rats weighing 200-250 g were 
divided into six groups. The first (Control (C), n=24) and second to eliminate nicotine 
effect on control group (Control and nicotine (CN), n=24) groups comprised freely-
moving control rats; groups 3 (REMsd (R), n=24) and 4 (REMsd and nicotine (RN), 
n=24) consisted of rats with REMsd induced using the inverted flower pot technique for 
72 hours; and the fifth (Wide platform (W), n=24) and sixth (Wide platform and 
nicotine (WN), n=24) groups comprised rats which were exposed to the same 
experimental environment as the REM sleep-deprived rats, however, the inverted flower 
pot used for this group was wider, hence enabling the rats to sleep. The C, R, and W 
groups were injected with normal saline subcutaneously while the CN, RN and WN 
groups were injected with 1 mg/kg nicotine subcutaneously every 12-hourly for 72 
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hours. The Morris Water Maze (MWM) (n=36) instrument was used to determine the 
spatial learning and memory performances, by which the initial 5 days was for the 
‗escape latency’ test and the final day ‗probe’ test. Food consumption and body weight 
gain were measured for all groups during adaptation, 72 hours induction period, and 
during MWM period. For each group, hippocampi were removed for 
immunohistochemistry (IHC) (n=36), Western blotting (WB) (n=36), and transmission 
electron microscopy (TEM) analysis (n=36) separately. The REMsd in the R and RN 
groups was confirmed by REMsd-induced hyperphagia and weight loss. In the rats of R 
group, there was marked spatial and memory impairment; TEM analysis showed 
damages in the cytoplasm, nuclei, mitochondria, rough endoplasmic reticulum (RER) 
and golgi apparatus (GA);  IHC showed that these rats had higher total number of 
DREAM-positive neurons, but lower total number of pCREB- and BDNF-positive 
neurons in the ‗cornu ammonis’ (CA) - CA1, CA2 CA3, and ‗dentate gyrus’ (DG) 
hippocampal regions; and these results were consistent with those of the WB analysis. 
Nicotine-treated group RN rats, showed reduction of REMsd effects. In conclusion, this 
study showed that acute nicotine treatment in REMsd reduced impairments in spatial 
learning and memory by (1) attenuating the hippocampal ultrastructure damage, (2) 
reducing the DREAM protein expression and level, and (3) increasing the pCREB and 
BDNF protein expressions and levels, in the hippocampi of REMsd rats. 
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CHAPTER 1  
INTRODUCTION 
1.1 SLEEP 
Sleep is one of the physiological needs in human and most of the living 
organisms. While sleeping, one will become senseless to the surroundings and is unable 
to remember any activities occurred during this phase. Thus, it is regarded as a resting 
state in which the body becomes inactive, the muscles relaxed, the eyes closed and the 
mind is unconscious (Datta and MacLean, 2007). This observation eventually yields to 
the conclusion that sleep is a passive state of the whole body and mind. It is a time for 
rest and recovery from the stresses of everyday life. 
In contrast to the perception, previous studies revealed that sleep is indeed an 
active condition. Apart from energy restoration, sleep enhances the process of 
biosynthesis as well as cellular and subcellular membrane repair (Mackiewicz et al., 
2007; Maret et al., 2007; Vyazovskiy and Harris, 2013; Ribeiro-Silva et al., 2016). It 
also provides protection against oxidative stress (Silva et al., 2004; Periasamy et al., 
2015), modulates gene expression (Guzman-Marin et al., 2006; Grønli et al., 2014), 
increases the brain protein synthesis (Nakanishi, 1997; Grønli et al., 2014) which in turn 
promotes neurogenesis (Guzman-Marin et al., 2007; Guzman-Marin et al., 2008). As a 
result, sleep contributes significantly to the process of learning and memory (through 
memory encoding and consolidation) and brain plasticity (Samkoff and Jacques, 1991; 
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Peigneux et al., 2001; McDermott et al., 2003; Walker and Stickgold, 2006; Walker, 
2008).  
1.1.1 History of sleep study  
The phenomenon of sleep has been contemplated by the philosophers since the 
Vedic civilisation, from 16
th
 to 11
th
 century B.C. (Datta et al., 2005; Datta and 
MacLean, 2007). However, scientific studies of sleep began with the discoveries of 
electroencephalogram (EEG) (Datta and MacLean, 2007). Datta and MacLean (2007) 
reviewed that in the mid 30‘s, Loomis and his colleagues showed the differences 
between waking, sleep and dreaming EEG patterns on human subjects. They also 
reviewed a work by Klaue in 1937 using cats as subjects. According to Datta and 
MacLean (2007), Klaue had discovered that EEG showed two different patterns during 
sleep. The first pattern was slow cortical waves occurred during light sleep, followed by 
speed up waves at the time of deep sleep (Klaue, 1937; Datta and MacLean, 2007).  
In 1953, Aserinsky and Kleitman conducted several series of sleep experiments 
involving normal adult subjects, and recorded the movement of the eye (using 
electrooculogram (EOG)), gross body, EEG, as well as heart and respiratory rates during 
sleep. They found out that 3 hours after sleep begins, the eyes rapidly moved, EEG 
pattern together with the pulse and respiratory rate increased, lasted on the average of 20 
minutes (Aserinsky and Kleitman, 1953). This cluster reoccurred around 2 hours (on 
average) after the first appearance (Aserinsky and Kleitman, 1953), and discovered it 
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was related to dream (Aserinsky and Kleitman, 1953; Dement and Kleitman, 1957), in 
which Dement and Kleitman (1957) called it rapid eye movement (REM) sleep. 
To get a clear definition of REM sleep, a study using sleeping cats a year later has 
been established, which led to two different cortical EEG patterns called ‗sleep pattern‘ 
(slow rhythms with higher voltage, and some spindle patterns waves) and ‗activated 
sleep pattern or REM sleep‘ (fast rhythms with low voltage waves) (Dement et al., 
1958). It was in this study, Dement and his teams initially used water tank technique to 
deprive the sleep of the studied cats, and evaluate EEG patterns in sleep deprived cats. 
Several other researchers also noticed two different patterns of sleep which were said to 
be slow wave sleep (SWS), later known as non-rapid eye movement sleep (NREM); and 
paradoxical sleep (PS), which is known as REM sleep (Suchecki et al., 2000; Datta and 
MacLean, 2007) (Figure 1.1). As the name implies, PS sleep (NREM sleep) indicates 
that during this sleep stage, the brain gets activated, however, this condition is contrary 
with muscle tone, in which muscle become weak or known as atonia (Suchecki et al., 
2000; Datta and MacLean, 2007).  
1.1.2 Sleep process 
Before sleep is initiated, our body is in the state of wakefulness. While awake, we 
are aware of our surroundings and muscles are active. Previous studies utilised 
polysomnography to study this phase (Aston-Jones and Bloom, 1981; Aeschbach et al., 
2008; Seibt et al., 2012). Thus, it is essential to discuss the waking state and waking-
  4  
 
promoting system in order to understand the generation of sleep as well as types of 
sleep. 
Waking and sleep stages can be distinguished using three associated cardinal 
physiological parameters, namely brain wave activities, eye movements, and muscle 
tone. Therefore, each of this state can be studied using polysomnogram, which consists 
of the combination of EEG (brain activities), EMG (muscle tone) and EOG (eye 
movements) (Datta and MacLean, 2007).  
1.1.2(a) Waking state  
Waking state can be divided into two stages, which are active and quiet waking 
(Aston-Jones and Bloom, 1981). Active waking stage is described by the exploratory 
and alert state in which EEG showed a high frequency but a low amplitude and non-
periodic signal. Meanwhile, EMG portrays a high amplitude tonic activity with frequent 
phasic bursts (Aston-Jones and Bloom, 1981). The EMG in quiet waking state displays 
similar pattern with the active state but lesser phasic burst, while EEG demonstrates the 
lack of spindle activity with about twice the amplitude as well as more periodic signals 
(Hobson, 2005) (Figure 1.1). 
 
 
 
  5  
 
 
 
 
 
 
 
 
 
Figure 1.1: Waking and sleep stages. Adapted from Hobson (2005). 
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1.1.2(b) Wake-promoting system  
In 1916, a Viennese neurologist, Von Economo began to observe his patients that 
slept excessively and this condition is known as encephalitis lethargica (Saper et al., 
2005; Schwartz and Roth, 2008). He was the first that reported the ascending arousal 
system that kept the forebrain awake and this system originates in the brainstem (Saper 
et al., 2005). Thirty years later, Moruzzi and Magoun studied the same system and 
introduced it as the wake-promoting system, by which activation of this system is 
responsible for the alertness of an organism and prevents it from falling asleep (Jones, 
2005; Datta and MacLean, 2007; Schwartz and Roth, 2008). 
Some groups of neurons that make up the wake-promoting systems are located 
within the ascending reticular activating system (ARAS) (situated within the rostral of 
pons through midbrain reticular formation) and secrete their own types of 
neurotransmitter (Jones, 2005b; Saper et al., 2005; Datta and MacLean, 2007). These 
wake-promoting groups of cells are: noradrenergic cells in the locus coeruleus (LC), 
serotoninergic cells in the raphe nuclei (RNc), cholinergic cells in the pedunculopontine 
tegmentum (PPT), glutamatergic cells in the midbrain, and dopaminergic cells in the 
substantia nigra compacta (SNc) and ventral tegmental area (VTA) (Figure 1.2). 
1.1.2(c) Sleep initiation 
Initiation of sleep in human is a complex passive process and this happens during 
stage 1 of sleep by which the waking stage is shifted to the NREM phase (Datta and 
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MacLean, 2007; Datta, 2010) (Figure 1.1). The most preferred theory in understanding 
this event is reticular deactivation theory. This theory posits that the reduction of 
ascending impulses from the reticular formation that maintains the brain activity during 
wakefulness is responsible for sleep (Datta and MacLean, 2007; Datta,  
2010). Therefore, the phase of sleep initiation occurs when the ascending impulses 
activity is decreasing. 
In 2007, after gathering more information about physiological changes of sleep 
initiation, Datta and his colleague, MacLean, came out with the theory of ―activity-
dependent metabolites homeostatic‖ to explain the transition period of wakefulness to 
sleep. The sleep initiating metabolic factors that are important in metabolites 
homeostasis are neuroinhibitory amino acids, gamma-aminobutyric acid (GABA), 
glycine, adenosine, prostaglandin D2 (PGD2) and cytokines such as interleukin-I beta 
(IL-1β) and tumour necrosis factor alpha (TNFα) (Datta, 2010). According to this 
theory, metabolic factors are increasing while awake, but the clearance rate is lower, 
thus they accumulate inside the body and brain (Datta, 2010). When these metabolites 
reach the certain threshold, they need to be reduced to the basal level (Datta and 
MacLean, 2007; Datta, 2010). This is to ensure that the homeostasis of metabolites will 
take place by clearing the accumulated metabolites and reducing the metabolites 
production rates (Datta and MacLean, 2007; Datta, 2010). Thus, the body and brain 
react by lowering the activity of the wake-promoting neuronal system. As a result, sleep 
is initiated (Datta and MacLean, 2007; Datta, 2010). 
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Figure 1.2: A schematic drawing showing key components of the ascending arousal 
system. The groups of neurons that are responsible to the wake-promoting system 
located in LC (locus coeruleus), RNc (raphe nuclei), PPT (pedunculopontine 
tegmentum), SNc (substantia nigra compacta) and VTA (ventral tegmental area). 
Adapted from Saper et al. (2005). 
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1.1.3 Sleep categories 
From the scientific perspective, sleep is described as a physiological process 
occurring as a result of the reduction of receptivity toward the exterior stimuli which 
coexists with a loss of consciousness (Rasch and Born, 2013). Sleep has been 
categorized into two phases known as the non-rapid eye movement (NREM) and rapid 
eye movement (REM) (Smith, 1995; Maquet, 2001; Hobson, 2005). The full cycle 
between NREM and REM in human is around 90 minutes while in rodents is 
approximately 10 minutes (Trachsel et al., 1991; Benington et al., 1994; Prince and 
Abel, 2013). 
1.1.3(a) NREM sleep phase 
NREM sleep phase occurs after the initiation of sleep, controlled by the activity of 
waking promoting systems in which the neuronal activity in thalamocortical networks 
depends on the metabolites level in the brain. Therefore, both the wake-promoting 
system and brain metabolites level are responsible for controlling the incoming sensory 
signals from the thalamus to the cerebral cortex. 
Thalamo-cortical relay neurons (neurons that relay sensory information to the 
cortex) and thalamic reticular neurons (prevent thalamocortical relay neurons from 
transferring sensory information to the cortex when activated), are two types of neurons 
in the thalamus that are responsible for NREM sleep phase (Steriade et al., 1993; 
Steriade and Timofeev, 2003; Datta, 2010). In generating NREM sleep, the increment of 
  10  
 
waking promoting system and metabolites, GABAB during wakefulness should be 
reduced (Datta and MacLean, 2007; Datta, 2010). Increasing of metabolites, such as 
GABAB, causes the excitation of thalamic reticular cells. When thalamic reticular cells 
are activated, they will inhibit the thalamocortical relay neurons and block the 
transmission of sensory impulses to the cortex, which leads to the generation of NREM 
sleep phase (Datta, 2010).  
The different stages of NREM sleep phase can be identified using cortical EEG 
recordings. There are four stages of NREM sleep phase in human, namely stage I, II, III 
and IV (Maquet, 2001; Hobson, 2005; Pizza et al., 2011) as shown in Figure 1.1. Stage I 
shows the transition of wakefulness and NREM sleep phase (Pizza et al., 2011). Then, 
stage II takes place and is characterised by the presence of K complex (a negative sharp 
wave followed by slower positive component) and slow oscillation with peculiar sleep 
spindles (Pizza et al., 2011). Finally, stage III and IV, which are characterised by the 
presence of low-frequency wave activity which indicates the deepest sleep of NREM 
and termed as Slow Wave Sleep (SWS) (Maquet, 2001; Pizza et al., 2011). In animals 
such as cat, rats and mouse, there are only two stages of NREM sleep phase known as 
stage SWS I and SWS II (Datta and MacLean, 2007). 
1.1.3(b) REM sleep phase 
REM sleep phase generation is relatively more complex than NREM sleep phase. 
During the REM sleep, cortical EEG shows relatively fast rhythm and low amplitude, 
while eye ball rapidly moves and muscle tone becomes weak. This phenomenon is 
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known as paradoxical sleep (PS) (Maquet, 2001; O‘Malley and Datta, 2013). It is also 
referred to as highly activated brain in a paralysed body (Maquet, 2001; O‘Malley and 
Datta, 2013). There are also other signs of REM sleep such as fluctuations in core body 
temperature and cardio-respiratory rhythms (Datta and MacLean, 2007). Furthermore, 
invasive EEG in non-human primates (Tamura et al., 2013) and rats (Colgin, 2016) 
shows slow activity (theta) rhythm in the hippocampus as well as P-waves, a spiky field 
potentials in the pons, lateral geniculate nucleus, and occipital cortex, which leads to the 
occurrence of vivid dreaming (Hutchison and Rathore, 2015).  
These signs of REM sleep will occur when groups of neurons called REM-
promoting neurons are activated and reach the certain threshold (Datta, 2010). The 
neurotransmitter that is essential in producing the set of REM signs is cholinergic 
neurotransmitter acetylcholine (ACh) that acts by exciting the populations of brainstem 
reticular formation neurons (Hobson, 2009; Ranjan et al., 2010). There are other 
neuronal populations called REM-off neurons. These neurons release aminergic 
neurotransmitter serotonin (5-HT) or noradrenaline (NA) (Hobson, 2009; Ranjan et al., 
2010).  
 The physiological mechanism of REM sleep execution has been explained by 
cellular-molecular-network (CMN) model (Datta and MacLean, 2007; Datta, 2010). 
REM sleep starts from the activation of REM-promoting neurons, which are located in 
the pons and midbrain (Datta and MacLean, 2007; Datta, 2010). It then propagates to 
the basal forebrain (Ballinger et al., 2016). According to the CMN model, REM sleep is 
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not regulated from a single centre, but is composed of several groups of distinct cells 
that are widely distributed as a network (Datta and MacLean, 2007; Datta, 2010). 
In generating the REM sleep signs, these groups of network cells are initially 
excited by the increased level of ACh neurotransmitter, released from the cholinergic 
neurons in the pedunculopontine tegmentum (PPT) and laterodorsal tegmentum (LDT). 
The medial pontine reticular formation (mPRF) is then activated and consequently lead 
to the reduction or absent level of NA neurotransmitter (from the noradrenergic neurons 
in the locus coeruleus (LC)) and 5-HT neurotransmitter (from the aminergic neurons in 
the raphe nucleus (RNc)) (Datta and MacLean, 2007; Datta, 2010). 
Activation of mPRF will then trigger activation of the cholinergic neurons in the 
basal forebrain (BF) which sends its projection to the hippocampus, neocortex, and 
amygdala (Woolf, 1991; Baghdoyan et al., 1993; Ballinger et al., 2016). Therefore, the 
interaction of REM-on and REM-off network cells as well as the oscillating changes 
between the above neurotransmitters that eventually generates the REM sleep signs 
(Figure 1.3). 
 
 
  
 
 
  13  
 
 
 
 
 
Figure 1.3: The expression of REM sleep using Cellular-Molecular-Network (CMN) 
model on the activity of cholinergic and aminergic system. Adapted from Datta and 
MacLean (2007). 
PPT - pedunculopontine tegmentum 
LDT - laterodorsal tegmentum 
ACh - acetylcholine 
mPRF - medial pontine reticular formation 
REM - rapid eye movement 
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1.1.3 (c) Mechanism of REM sleep generation 
Initiation of sleep begins in the area rich of cholinergic neurons known as PPT and 
LDT. At first, kainate receptors on the cholinergic neurons are activated by the release 
of glutamate (Datta and Siwek, 2002; Datta and MacLean, 2007). This triggers the 
release of ACh from cholinergic cells (Datta and Siwek, 2002; Datta and MacLean, 
2007). The ACh activates each of the groups that generate REM sleep signs and REM 
sleep-inducing site in the mPRF. During activation of cholinergic cells in PPT and LDT, 
the noradrenergic neurons in the LC and serotonergic neurons in the RNc are inhibited 
by GABAergic cells located in those particular areas (Datta and MacLean, 2007; Datta, 
2010). Therefore, the release of aminergic neurotransmitter is reduced, and this 
modulation initiates the REM sleep signs (Datta and MacLean, 2007; Datta, 2010). 
1.1.3 (d) REM sleep maintenance 
The episodes of REM sleep maintenance depend on the ratio between cholinergic 
and aminergic neurotransmitters within the cell groups (Datta and Siwek, 2002; Datta 
and MacLean, 2007; O‘Malley and Datta, 2013). During wakefulness and NREM sleep, 
the REM sleep sign-generator remains in the turned-off condition by which the ratio of 
aminergic and cholinergic neurotransmitter is 1:1 (Datta, 2010; O‘Malley and Datta, 
2013). In this case, the activity of aminergic and cholinergic neurons is proportionate 
and the activity of both types of neurons show approximately the same level of activity 
during wakefulness. It is also noted that during NREM sleep the activities of both types 
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of neurons are equally reduced (Datta and MacLean, 2007; Datta, 2010; O‘Malley and 
Datta, 2013). 
However, at the time of REM sleep, the ratio of aminergic to cholinergic activity 
is 0:0.6, which indicates the inhibition of the aminergic activity while the activity of 
cholinergic neurons is comparatively high and more active than in wake (Datta and 
Siwek, 2002; Datta and MacLean, 2007; Datta 2010; O‘Malley and Datta, 2013). This 
results in a brain state that is largely deficient in aminergic modulation and dominated 
by acetylcholine (Walker and Stickgold, 2004). 
The activity of cholinergic cells in PPT and LDT is maintained by the continuous 
activation of glutamate that is released from the ACh-induced mPRF activity (Datta and 
MacLean, 2007; Datta, 2010). The glutamate also activates the aminergic and 
GABAergic cells in the LC and RNc; however, the inhibition of LC and RNc precedes 
the activation of aminergic cells due to the local release of GABA in the LC and RNc 
(Datta and MacLean, 2007; Datta, 2010). In addition to that, the activation of mPRF also 
stimulates the BF cholinergic neurons, in which hippocampus receives the majority of 
the cholinergic input from the BF via two nuclei, the medial septal (MS) and diagonal 
band (DB) (Woolf, 1991; Ballinger et al., 2016). 
1.2 REM SLEEP DEPRIVATION 
Sleep is vital for the good health, well-being and support of life. An animal model 
has been accepted as a potentially useful strategy in order to understand the functions 
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and the regulation of REM sleep as well as its deprivation (Pedrazzoli et al., 2009; 
Orzeł-Gryglewska, 2010; Colavito et al., 2013; Toth and Bhargava, 2013). 
1.2.1 REM sleep deprivation (REMsd) models 
The model for REMsd can be developed in animals using a simple technique 
known as classic platform method, which is either a single-platform or multiple-
platform method (Medeiros et al., 1998; Suchecki et al., 1998; Machado et al., 2004; 
Machado et al., 1998; Mueller et al., 2008; Alkadhi et al., 2013). 
 In 1964, the single inverted flower pot method was developed by Jouvet and his 
co-worker to elicit the sleep loss in cats. Then a year later, Cohen and Dement adapted 
this method to rats (Suchecki et al., 1998; Machado et al., 2004; Tufik et al., 2009). 
Using this model, there is a confined tank filled with water, that surrounds a single 
platform usually 6.5 cm in diameter, in which a rat is placed on top of it. The 
surrounding water is at a specified level such that the rat will be slipped into the water 
when it undergoes loss of muscle tone (atonia) induced by REM sleep. The animal 
awakens when in contact with water and this scenario prevents the occurrence of REM 
sleep (Suchecki et al., 1998; Machado et al., 2004; Tufik et al., 2009). This method 
leads to the REMsd-related morbidities (Koban and Swinson, 2005; Koban et al., 2008) 
while the occurrence of NREM sleep loss is minimum (Machado et al., 2006; Mueller et 
al., 2008).  
Previous studies have shown that the plasma adrenocorticotrophic hormone 
(ACTH) and plasma corticosterone increased in animals exposed to the single platform 
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technique due to stress induced by social isolation (Suchecki et al., 1998; Suchecki and 
Tufik, 2000). Other studies observed aggressive behaviour (Kushida et al., 1989; 
Martins et al., 2008; Orzeł-Gryglewska, 2010). In addition, some studies have shown 
that, immobilisation from the single flower pot deprived both REM and NREM sleep 
(Suchecki and Tufik, 2000; Pawlyk et al., 2008). 
Even though the single platform method has been used to produce REMsd, factors 
such as isolation stress, muscle fatigue due to movement restriction and wetness have 
become the confounding variables (Suchecki et al., 1998; Machado et al., 2004; 
Machado et al., 2006). Thus, in 1981, Van Hulzen and Coenen introduced multiple 
platform paradigms in which a rat is placed inside a larger water tank that contains 
several platforms, which enable the rat to ambulate and reduce the movement restriction 
(Gulyani et al., 2000; Machado et al., 2004). The multiple platform paradigm does 
exclude immobilization stress; however, stress due to social isolation cannot be 
eliminated (Suchecki et al., 2000; Suchecki and Tufik 2000; Machado et al., 2004; 
Machado et al., 2006). Using this method, the weight of adrenal gland was shown to 
increase and there was a reduction in the thymus weight due to stress (Coenen and Van 
Luutelaar, 1985). Thus, a modified multiple platform method is carried out in order to 
minimise the social isolation induced stress (Suchecki et al., 2000; Suchecki and Tufik, 
2000; Machado et al., 2004; Machado et al., 2006). 
The modified multiple platform model aiming to suppress REM sleep 
simultaneously in a group of rats involves many small platforms for a group of rats 
(Suchecki et al., 2000; Suchecki and Tufik, 2000; Machado et al., 2004; Machado et al., 
  18  
 
2006). However, this method results in more stress and lower occurrences of sleep 
episodes as compared to the previous single platform method (Medeiros et al., 1998; 
Machado et al., 2004). Even though this technique reduces the social isolation and 
locomotor restrictions, but the forced awakening secondary to social interactions results 
in stress with an associated increase of plasma corticosterone and ACTH levels 
(Suchecki et al., 1998; Suchecki and Tufik, 2000). Moreover, a study using large 
multiple platform revealed an elevation of ACTH levels of the rats though it was not as 
high as in rats that are exposed to the small multiple platforms (Suchecki et al., 1998). 
Hence, the social interactions in the water tank generate stress among study rats 
(Medeiros et al., 1998; Machado et al., 2004).  
Later, a method known as disk-over-water (DOW) is used to study chronic sleep 
deprivation (Landis et al., 1992; Rechtschaffen and Bergmann, 1995; Rechtschaffen et 
al., 1999; Lader et al., 2006). According to this paradigm, an experimental rat is placed 
on one side of a separated horizontal disk that is hanged over a shallow tray of 2 to 3 cm 
deep water (Landis et al., 1992; Rechtschaffen and Bergmann, 1995; Rechtschaffen et 
al., 1999; Lader et al., 2006). The disk was automatically rotated at low speed when the 
rat is starting to sleep and keep the rat awake, thus in order to avoid falling into the 
water, the rat was forced to walk in an opposite direction of the rotating disk 
(Rechtschaffen and Bergmann, 1995). During this procedure, sleep states were 
continuously monitored from the theta activity, EMG and EEG (Landis et al., 1992; 
Rechtschaffen and Bergmann, 1995; Rechtschaffen et al., 1999; Lader et al., 2006). This 
method has been shown to selectively deprive REM sleep by 86% (Landis et al., 1992; 
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Rechtschaffen and Bergmann, 1995) and can be as high as 99% (Kushida et al., 1989; 
Rechtschaffen and Bergmann, 1995). 
The different methods of sleep deprivation are not only to provide a model of 
sleep deprivation, but it is also to reduce (or eliminate) the other stress factor that may 
be developed during the deprivation process. This is because stress can be a 
confounding factor for the REMsd, thus it may generate comorbidities. 
1.2.2 Effect of REMsd on the animal behaviour 
Exposing REMsd to the animals may develop several effects that have been 
studied previously. REM sleep deprived rats fail to groom, this leads to progressive 
debilitation manifested in scrawny appearance with dishevelled, clumped and yellowing 
fur (Kushida et al., 1989; Rechtschaffen et al., 1989; Rechtschaffen and Bergmann, 
1995; Gulyani et al., 2000; Hossein et al., 2000). Other physical appearances that can be 
seen are aggressive behaviour (Medeiros et al., 1998; Suchecki and Tufik, 2000; Orzeł-
Gryglewska, 2010), weight loss and hyperphagia (Kushida et al., 1989; Rechtschaffen et 
al., 1989; Youngblood et al., 1997; Koban et al., 2006; Martins et al., 2008; Barf et al., 
2012). 
In addition, REM sleep-deprived animals showed several internal body changes 
such as increase of plasma catecholamines, hypothyroidism, reduced core temperature, 
elevated metabolic rate and energy expenditure (Rechtschaffen et al., 1989; 
Rechtschaffen and Bergmann, 1995; Koban et al., 2006; Mueller et al., 2008). 
Furthermore, hormonal studies have shown that anabolic hormones (Growth hormone 
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(GH), Insulin-like growth factor I (IGF-I), prolactin and leptin) are reduced in REM 
sleep-deprived animal (Everson and Crowley, 2004; Koban et al., 2006). 
 Two most important characteristics of REMsd are hyperphagia that was contrarily 
associated with loss of body weight (Rechtschaffen and Bergmann, 1995; Youngblood 
et al., 1997; Koban et al., 2006; Martins et al., 2008; Barf et al., 2012). In accordance 
with hyperphagia after REMsd, the hormones for food intake within the hypothalamus 
and brainstem known as neuropeptide Y (NPY), pro- opiomelanocortin (POMC) and 
leptin have changed (Mathieu-Kia et al., 2002; Koban and Swinson, 2005; Koban et al., 
2006; Koban et al., 2008; Moraes et al., 2014). These changes are due to the increase of 
the NYP gene expression within the hypothalamus while the POMC gene expression 
(the counterpart of NPY) decreased (Koban et al., 2006; Koban et al., 2008). In 
addition, after 5 days of REMsd, the secretion of a satiety hormone by white adipocytes, 
known as serum leptin (hormone that gives blunting appetite signal after binds to 
receptors within the hypothalamus and brainstem) decreased more than 50 percent in 
rats which demonstrated hyperphagia and loss of body weight (Koban and Swinson, 
2005). 
Studies have shown that REMsd increases resting metabolic rate, and thus reduces 
the body weight despite hyperphagia (Koban and Swinson, 2005; Koban et al., 2008; 
Martins et al., 2008). This hypermetabolic state is believed to be mediated via 
Uncoupling Protein 1 (UCP1), a 32 kDa inner mitochondria membrane protein that 
plays a major role in cellular respiration by allowing proton leakage, which resulted in 
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thermodynamic energy dissipating as heat in the cells of brown adipose tissue (Koban 
and Swinson, 2005; Koban et al., 2006; Martins et al., 2008; Christie et al., 2011). 
REMsd also leads to the increment of the energy expenditure by increasing the use 
of body fats and proteins but with a normal glucose uptake (Kushida et al., 1989; 
Rechtschaffen and Bergmann, 1995). Several studies confirmed that excessive use of the 
body fat leads to negative energy balance state, which in turn reduce the body weight 
(Koban and Swinson, 2005; Venancio and Suchecki, 2015). 
1.2.3 Effect of REMsd on the neuronal morphology 
The effects of REMsd on the morphology of neurons were first observed by 
Pieron in 1921 (Majumdar and Mallick, 2005). After REM sleep deprived, neurons 
become shrunken (Majumdar and Mallick, 2005; Biswas et al., 2006), nucleus showed 
an ectopic appearance of heterochromatin (Majumdar and Mallick, 2005), while nuclear 
volume decreased by 20-25% (Pedrazzoli et al., 2009). Other changes are vacuolization 
of the protoplasm, fragmentation and the disappearance of nissl and neurofibrils 
(Majumdar and Mallick, 2005). These changes confirmed that neuronal morphology and 
structure are both affected by REMsd (Majumdar and Mallick, 2005). However, the size 
of the neurons in rat brain cells changes and the changes are dependent on the 
physiological function and neurotransmitter content of the neuronal cells. For example, 
the size of cholinergic neurons decreases, but serotonergic neurons increase after 
REMsd (Rajan et al., 2010). Furthermore, in studying the occurence of apoptosis in 
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REM sleep-deprived rats, Biswas and his co-worker (2006) discovered that it occurs 
after 6 days of REMsd. 
1.2.4  Effect of REMsd on the learning and memory  
There is a large body of evidence from previous studies showing a strong 
correlation between sleep deprivation and learning and memory impairment in both 
humans and animals (Polzella, 1975; Smith, 1995; Smith and Rose, 1996; McDermott et 
al., 2003; Guan et al., 2004; Ferrara et al., 2008). REM sleep has an essential role in 
learning and memory formation in the hippocampus (Marshall and Born, 2007). 
Therefore, deprivation of REM sleep impairs hippocampus-dependent learning and 
memory (McDermott et al., 2006; Tartar et al., 2006; Alhaider et al., 2010; Aleisa et al., 
2011). In addition to that, the activity of hippocampus has reduced after sleep loss (Yoo 
et al., 2007), where EEG studies proved that sleep deprivation blocks long-term 
potentiation (LTP), in the hippocampal CA1 (McDermott et al., 2003; Kim et al., 2005; 
Tartar et al., 2006; Alhaider et al., 2010) and DG regions (Ishikawa et al., 2006), but 
increased long term depression (LTD) (Tadavarty et al., 2009) in the activity of neuron 
in CA1 and CA3 regions of the hippocampus. 
1.3 LEARNING AND MEMORY  
Learning and memory are fundamental higher brain functions which are closely 
related (Benfenati, 2013). According to the American Psychological Association, 
learning is the acquisition of knowledge or skill (Kazdin, 2000), whereas memory is the 
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process of retaining, reconstructing and expressing the acquired knowledge over time 
(Kandel et al., 2014). Learning and memory cannot be directly measured, thus it can be 
analysed from the performance changes of an organism under particular conditions 
(Davis and Squire, 1984). 
1.3.1 Learning in animal 
In animal, learning can be detected from their behaviour. Learning behaviour in 
the animal can be classified as non-associated learning, associated learning and 
cognition learning. The non-associative learning in animal behaviour is the simplest 
learning condition which are habituation (an animal stops responding after repeated 
stimulus) and imprinting (learning that occurs at development stage of certain animal, in 
which the young animal imitates their parents‘ behaviour) (Squire, 1992b). 
The associative learning is classified as the conditioning learning behaviour and 
operant conditioning. The conditioning learning behaviour can be further subdivided 
into conditional and unconditional stimulus (Squire, 1992b). According to Ivan Pavlov 
experiment using a dog, classical conditioning can be explained by a particular response 
(eg. dog is salivating) associated with one stimulus (eg. smell of food), and that stimulus 
is associated with a second stimulus (when the dog is trained with sound of bell 
accompanied with food, the dog will salivate, then with the sound of bell even without 
food, the dog will also salivate) (Squire, 1992b). Therefore, conditioning stimulus is the 
smell of food while unconditioning stimulus is the sound of bell ringing (Squire, 1992b). 
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Meanwhile, operant conditioning is when the reward or punishment will be given to 
animals after performing a behaviour (Squire, 1992b). 
Finally, the cognition learning behaviour is a sophisticated learning behaviour 
such as problem solving and spatial learning. In problem solving, a German scientist, 
Wolfgang Kohler performed an experiment using chimpanzees. Kohler hung a banana in 
chimpanzee cage, but too high for them to reach. He then placed several boxes on the 
floor. The chimpanzees demonstrated cognitive learning when they solved the problem 
by stacking the boxes and climbing them to reach the banana (Runco, 1990; Gould, 
2004). 
There are varieties of paradigm to investigate spatial learning and the commonly 
used one is Morris water maze (MWM), which is introduced by Richard Morris. Using 
this method, an animal (usually rodents) is placed in a tank containing water and the 
animal learns how to swim to find and escape on a submerged platform guided by 
external cues (Morris, 1984). Using spatial information (animal‘s capacity to remember 
spatial cues), this animal learns how to locate a hidden underwater platform and escape 
into it. Therefore, this task is classified as learning with explicit associative memory that 
involves cognitive mapping (Morris, 1984; Smith, 1995; Rasch and Born, 2013; Kandel 
et al., 2014). Thus in this study, we used MWM in developing rat‘s spatial learning and 
we focused on the explicit memory. 
